Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region, PLoS Neglected Tropical Diseases, vol.88, issue.8, p.3021, 2014. ,
DOI : 10.1371/journal.pntd.0003021.t003
Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High Sensitivity, Journal of Clinical Microbiology, vol.42, issue.11, pp.5249-55, 2004. ,
DOI : 10.1128/JCM.42.11.5249-5255.2004
Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature, Microbes and Infection, vol.7, issue.13, pp.1370-1375, 2005. ,
DOI : 10.1016/j.micinf.2005.06.002
Leishmaniasis in immunosuppressed individuals, Clinical Microbiology and Infection, vol.20, issue.4, pp.286-99, 2014. ,
DOI : 10.1111/1469-0691.12556
Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Tropica, vol.119, issue.2-3, pp.69-75, 2011. ,
DOI : 10.1016/j.actatropica.2011.05.012
The current status of zoonotic leishmaniases and approaches to disease control, International Journal for Parasitology, vol.35, issue.11-12, pp.1169-80, 2005. ,
DOI : 10.1016/j.ijpara.2005.07.001
A Randomised, Double-Blind, Controlled Efficacy Trial of the LiESP/QA-21 Vaccine in Na??ve Dogs Exposed to Two Leishmania infantum Transmission Seasons, PLoS Neglected Tropical Diseases, vol.25, issue.10, p.3213, 2014. ,
DOI : 10.1371/journal.pntd.0003213.g010
Traitement de la leishmaniose viscérale : modalités récentes, Presse Med, vol.28, pp.2057-66, 1999. ,
Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-137, 2006. ,
DOI : 10.1128/CMR.19.1.111-126.2006
Drug regimens for visceral leishmaniasis in Mediterranean countries, Tropical Medicine & International Health, vol.15, issue.Suppl. 1, pp.1272-1278, 2008. ,
DOI : 10.1111/j.1365-3156.2008.02144.x
Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.90, issue.5, pp.574-581, 1996. ,
DOI : 10.1016/S0035-9203(96)90330-2
Reviews Of Anti???infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis, Clinical Infectious Diseases, vol.43, issue.7, pp.917-941, 2006. ,
DOI : 10.1086/507530
Traitement des leishmanioses en France??: proposition d???un r??f??rentiel consensuel, La Presse M??dicale, vol.40, issue.2, pp.173-84, 2011. ,
DOI : 10.1016/j.lpm.2010.09.023
Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum, Journal of Antimicrobial Chemotherapy, vol.40, issue.2, pp.287-296, 1997. ,
DOI : 10.1093/jac/40.2.287